MARSHALL WACE, LLP – Bio-Rad Laboratories, Inc. Transaction History
MARSHALL WACE, LLP portfolio value:
$71.99M
portfolio value
MARSHALL WACE, LLP quarter portfolio value change:
-15.73%
quarter
Bio-Rad Laboratories, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -23.21% | -52.16K shares | -39.26M | $417.14 | 172.6K |
Q2 2022 | share | Decrease | -51.90% | -242.57K shares | -151.96M | $495 | 224.76K |
Q1 2022 | share | Increase | +40.19% | 133.97K shares | 11.34M | $563.23 | 467.34K |
Q4 2021 | share | Decrease | -24.12% | -105.97K shares | -75.84M | $758.65 | 333.37K |
Q3 2021 | share | Increase | +0.98% | 4.24K shares | 47.39M | $745.95 | 439.34K |
Q2 2021 | share | Decrease | -23.52% | -133.81K shares | -44.61M | $644.29 | 435.09K |
Q1 2021 | share | Increase | +54.01% | 199.50K shares | 109.60M | $571.17 | 568.91K |
Q4 2020 | share | Increase | +31.67% | 88.84K shares | 70.72M | $582.94 | 369.41K |
Q3 2020 | share | Increase | +20.36% | 47.46K shares | 39.37M | $515.46 | 280.56K |
Q2 2020 | share | Increase | +107.66% | 120.85K shares | 65.89M | $451.49 | 233.10K |
Q1 2020 | share | Increase | +12967.75% | 111.39K shares | 39.03M | $350.56 | 112.25K |
Q4 2019 | share | Decrease | -98.91% | -77.89K shares | -25.88M | $370.03 | 859 |
Q3 2019 | share | Increase | +266.73% | 57.28K shares | 19.49M | $332.74 | 78.75K |
Q2 2019 | share | Increase | 0.00% | 21.47K shares | 6.71M | $312.59 | 21.47K |
Q1 2019 | share | Decrease | -100.00% | -9.19K shares | -2.13M | $305.68 | 0 |
Q4 2018 | share | Decrease | -61.62% | -14.76K shares | -5.36M | $232.22 | 9.19K |
Q3 2018 | share | Increase | +669.77% | 20.85K shares | 6.60M | $312.99 | 23.96K |
Q2 2018 | share | Increase | 0.00% | 3.11K shares | 898K | $288.54 | 3.11K |
Q3 2017 | share | Decrease | -100.00% | -1.11K shares | -252K | $222.22 | 0 |
Q2 2017 | share | Increase | 0.00% | 1.11K shares | 252K | $226.31 | 1.11K |